Ethics and Psychedelics

This study presents a range of ethical issues that arise when considering the use of psychedelic substances within medicine.

Psychedelics are, by their nature, boundary-dissolving, and it is suggested that progress in the Ethics of Psychedelic Medicine is best made within a broader-ranging Psychedelic Bioethics, which encompasses not just medicine, but wider society, including the breadth of cultural containers and settings in which these compounds are used.

Read more

Psychedelics, Alcoholism and PTSD

This study evaluated prospective associations of ibogaine and 5-MeO-DMT treatment for risky alcohol use and post-traumatic stress disorder (PTSD) symptoms among United States (US) Special Operations Forces Veterans (SOFV).

Future clinical trials should determine whether psychedelic-assisted therapy holds promise for individuals with complex trauma and alcohol misuse who have not been successfully treated with traditional interventions.

Read more

More on the Therapeutic Potential of Mushrooms

Fred Barrett, a neuroscientist at the Johns Hopkins Center for Psychedelic & Consciousness Research, discusses the revolutionary healing potential of psilocybin, what is not yet known about the compound’s role in treating various psychiatric disorders, the importance of the “therapy” aspect of psychedelic-assisted therapy, and the hurdles that remain to this treatment being accessible to the general public.

Read more

Studying Psychedelics- Design and Research

How much does a person’s subjective experience and expectation of a psychedelic trip, as opposed to only the drug’s chemical effects on the brain, influence the drug’s ability to alleviate conditions like depression, addiction, or post-traumatic stress disorder?

Now that psychedelics are being noticed by federal regulators and the public, scientists are again asking: What’s the best way to study these compounds in order to truly understand their effects?

Read more